These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 37123460)

  • 1. The Relationship Between Innovation and Corporate Performance in Japanese SMEs by Two-Stage Panel Data Analysis: Focusing on the Joint Effect of ICT and R&D.
    Matsuzaki T; Shigeno H; Bunno T; Idota H; Tsuji M
    Rev Socionetwork Strateg; 2023; 17(1):55-71. PubMed ID: 37123460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ICT and higher-order capabilities on the performance of Ibero-American SMEs.
    Gaviria-Marin M; Matute-Vallejo J; Baier-Fuentes H
    Comput Math Organ Theory; 2021; 27(4):414-450. PubMed ID: 34127907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the effects of ICT on innovation and performance of European hospitals: an exploratory study.
    Arvanitis S; Loukis EN
    Eur J Health Econ; 2016 May; 17(4):403-18. PubMed ID: 25822165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge transfer and innovation performance of small and medium enterprises (SMEs): An informal economy analysis.
    Ibidunni AS; Kolawole AI; Olokundun MA; Ogbari ME
    Heliyon; 2020 Aug; 6(8):e04740. PubMed ID: 32885077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming pandemic challenges through product innovation: The role of digital technologies and servitization.
    Bettiol M; Capestro M; Di Maria E; Micelli S
    Eur Manag J; 2022 Oct; 40(5):707-717. PubMed ID: 36531936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of self efficacy and sharia financial literacy to SMES performance: business model as intermediate variable.
    Srisusilawati P; Malik ZA; Silviany IY; Eprianti N
    F1000Res; 2021; 10():1310. PubMed ID: 36339113
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategic orientation, business model innovation and corporate performance-Evidence from construction industry.
    Han W; Zhou Y; Lu R
    Front Psychol; 2022; 13():971654. PubMed ID: 36337575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forms of extramural research acquisition and product innovation: Data from econometric estimations.
    Carboni OA; Medda G
    Data Brief; 2021 Dec; 39():107567. PubMed ID: 34825033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do R&D intensity and capacity utilisation matter for SMEs' innovations within the CEE region? Testing moderating roles of different ownership structures.
    Darfo-Oduro R; Prokop V; Stejskal J; Klímová V; Žítek V
    PLoS One; 2024; 19(1):e0296873. PubMed ID: 38215159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of collaborative innovation on ICT-based technological convergence: A patent-based analysis.
    Hwang I
    PLoS One; 2020; 15(2):e0228616. PubMed ID: 32017795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of open innovation, hotel service quality and marketing strategy in hotel business performance.
    Azhar Mohd Harif MA; Nawaz M; Hameed WU
    Heliyon; 2022 Sep; 8(9):e10441. PubMed ID: 36119852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How does venture capital cross-border syndication spur corporate innovation? Evidence from China.
    Hao H; Guo L; Dong J
    Front Psychol; 2022; 13():921168. PubMed ID: 35936306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkages Between Knowledge Management Process and Corporate Sustainable Performance of Chinese Small and Medium Enterprises: Mediating Role of Frugal Innovation.
    Kun M
    Front Psychol; 2022; 13():850820. PubMed ID: 35391966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations.
    Årdal C; Baraldi E; Theuretzbacher U; Outterson K; Plahte J; Ciabuschi F; Røttingen JA
    J Pharm Policy Pract; 2018; 11():8. PubMed ID: 29632669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Technological Acquisition and R&D Expenditure in Innovative Investment.
    Weiyu Z; Othman A; Guli T
    Front Psychol; 2022; 13():855295. PubMed ID: 35478744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplier concentration and corporate innovation input.
    Zou M; Zhang X
    Front Psychol; 2022; 13():879706. PubMed ID: 36353086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Notion of Coopetition-Based Open-Innovation in Business Practices: A Model to Accelerate Firm Performance.
    Avotra AARN; Chengang Y; Said KSM; Chu C; Xiang L
    Front Psychol; 2022; 13():931623. PubMed ID: 36033056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does public subsidy promote sustainable innovation? The case of Chinese high-tech SMEs.
    Xiang D; Zhao T; Zhang N
    Environ Sci Pollut Res Int; 2021 Oct; 28(38):53493-53506. PubMed ID: 34036503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey data on inter-firm linkages and innovation activities of Chinese manufacturing SMEs.
    Mei L; Zhang T; Chen J
    Data Brief; 2019 Dec; 27():104671. PubMed ID: 31720326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What affects the innovation performance of small and medium-sized enterprises (SMEs) in the biotechnology industry? An empirical study on Korean biotech SMEs.
    Kang KN; Lee YS
    Biotechnol Lett; 2008 Oct; 30(10):1699-704. PubMed ID: 18506395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.